HUMAN METAPNEUMOVIRUS
Clinical trials for HUMAN METAPNEUMOVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN METAPNEUMOVIRUS trials appear
Sign up with your email to follow new studies for HUMAN METAPNEUMOVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo vaccine aims to shield seniors from two dangerous respiratory viruses
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine that targets two respiratory viruses—RSV and hMPV—in adults aged 60 and older. The goal was to see if the vaccine is safe and triggers a strong immune response. Participants received either a single shot or a booster after 12 months, and researcher…
Matched conditions: HUMAN METAPNEUMOVIRUS
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:53 UTC
-
Nasal spray vaccine shows promise against childhood lung virus
⭐️ VACCINE ⭐️ CompletedThis study tested two experimental nasal spray vaccines designed to protect children against human metapneumovirus (HMPV) and parainfluenza virus type 3 (HPIV3), both of which can cause serious breathing problems. Twenty-four children aged 2 to 5 who already had antibodies to HPI…
Matched conditions: HUMAN METAPNEUMOVIRUS
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 11:59 UTC